UroGen Pharma Ltd. ( URGN) - Key Metrics
URGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.77 | -$0.54 | -$0.78 | -$0.78 |
| 2025Q3 | $0.57 | -$0.69 | -$0.88 | -$0.88 |
| 2025Q2 | $0.51 | -$1.05 | -$0.83 | -$0.84 |
| 2025Q1 | $0.43 | -$0.92 | -$0.89 | -$0.89 |
URGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -10.93 |
| 2025Q3 | ? | -7.19 |
| 2025Q2 | ? | -3.27 |
| 2025Q1 | ? | -2.99 |
URGN
Price: $40.97
52 week price:
Earnings Per Share: -2.74 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20983
Ebitda: -286000Market Capitalization: 1.9 billion